Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

Cancer is the leading cause of death in China and depicting the cancer pattern of China would provide basic knowhows on how to tackle it more effectively. In this study we have reviewed several reports of cancer burden, including the Global cancer statistics 2018 and Cancer statistics in China, 2015, along with the GLOBCAN 2018 online database, to investigate the differences of cancer patterns between China, the United States (USA) and the United Kingdom (UK). An estimated 4.3 million new cancer cases and 2.9 million new cancer deaths occurred in China in 2018. Compared to the USA and UK, China has lower cancer incidence but a 30% and 40% higher cancer mortality than the UK and USA, among which 36.4% of the cancer-related deaths were from the digestive tract cancers (stomach, liver, and esophagus cancer) and have relatively poorer prognoses. In comparison, the digestive cancer deaths only took up ≤ 5% of the total cancer deaths in either USA or UK. Other reasons for the higher mortality in China may be the low rate of early-stage cancers at diagnosis and non-uniformed clinical cancer treatment strategies performed by different regions. China is undergoing the cancer transition stage where the cancer spectrum is changing from developing country to developed country, with a rapidly increase cancer burden of colorectal, prostate, female breast cancers in addition to a high occurrence of infection-related and digestive cancers. The incidence of westernized lifestyle-related cancers in China (i.e. colorectal cancer, prostate, bladder cancer) has risen but the incidence of the digestive cancers has decreased from 2000 to 2011. An estimated 40% of the risk factors can be attributed to environmental and lifestyle factors either in China or other developed countries. Tobacco smoking is the single most important carcinogenic risk factor in China, contributing to ~ 24.5% of cancers in males. Chronic infection is another important preventable cancer contributor which is responsible for ~ 17% of cancers. Comprehensive prevention and control strategies in China should include effective tobacco-control policy, recommendations for healthier lifestyles, along with enlarging the coverage of effective screening, educating, and vaccination programs to better sensitize greater awareness control to the general public.

[1]  P. González,et al.  Present status of human papillomavirus vaccine development and implementation. , 2015, The Lancet. Oncology.

[2]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[3]  R. K. Hogben Screening for breast cancer in England: a review , 2008, Current opinion in obstetrics & gynecology.

[4]  N. Muñoz,et al.  Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. , 2010, The Lancet. Oncology.

[5]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[6]  D. Forman,et al.  Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind , 2018, Journal of cancer policy.

[7]  A. Gavin,et al.  The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015 , 2018, British Journal of Cancer.

[8]  Brian A. King,et al.  Current cigarette smoking among adults - United States, 2005-2014. , 2015, MMWR. Morbidity and mortality weekly report.

[9]  E. Unger,et al.  Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. , 2013, The Journal of infectious diseases.

[10]  I. Soerjomataram,et al.  Status of implementation and organization of cancer screening in The European Union Member States—Summary results from the second European screening report , 2018, International journal of cancer.

[11]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.

[12]  S. Ng,et al.  Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. , 2017, Gastroenterology.

[13]  Ning Wang,et al.  Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. , 2018, The Lancet. Global health.

[14]  Ahmedin Jemal,et al.  Global trends of lung cancer mortality and smoking prevalence. , 2015, Translational lung cancer research.

[15]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[16]  Yu Wang,et al.  Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. , 2009, Vaccine.

[17]  Ahmedin Jemal,et al.  Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States , 2018, CA: a cancer journal for clinicians.

[18]  A. Jemal,et al.  Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013 , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  Brian A. King,et al.  Current Cigarette Smoking Among Adults — United States, 2005–2013 , 2014, MMWR. Morbidity and mortality weekly report.

[20]  Brian A. King,et al.  Current Cigarette Smoking Among Adults — United States, 2016 , 2015, MMWR. Morbidity and mortality weekly report.